Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation
- PMID: 16080193
- DOI: 10.1002/ijc.21355
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation
Abstract
We have previously demonstrated that, following acquisition of endocrine resistance, breast cancer cells display an altered growth rate together with increased aggressive behaviour in vitro. Since dysfunctional cell-cell adhesive interactions can promote an aggressive phenotype, we investigated the integrity of this protein complex in our breast cancer model of tamoxifen resistance. In culture, tamoxifen-resistant MCF7 (TamR) cells grew as loosely packed colonies with loss of cell-cell junctions and demonstrated altered morphology characteristic of cells undergoing epithelial-to-mesenchymal transition (EMT). Neutralising E-cadherin function promoted the invasion and inhibited the aggregation of endocrine-sensitive MCF7 cells, whilst having little effect on the behaviour of TamR cells. Additionally, TamR cells had increased levels of tyrosine-phosphorylated beta-catenin, whilst serine/threonine-phosphorylated beta-catenin was decreased. These cells also displayed loss of association between beta-catenin and E-cadherin, increased cytoplasmic and nuclear beta-catenin and elevated transcription of beta-catenin target genes known to be involved in tumour progression and EMT. Inhibition of EGFR kinase activity in TamR cells reduced beta-catenin tyrosine phosphorylation, increased beta-catenin-E-cadherin association and promoted cell-cell adhesion. In such treated cells, the association of beta-catenin with Lef-1 and the transcription of c-myc, cyclin-D1, CD44 and COX-2 were also reduced. These results suggest that homotypic adhesion in tamoxifen-resistant breast cancer cells is dysfunctional due to EGFR-driven modulation of the phosphorylation status of beta-catenin and may contribute to an enhanced aggressive phenotype and transition towards a mesenchymal phenotype in vitro.
Copyright 2005 Wiley-Liss, Inc.
Similar articles
-
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.Breast Cancer Res Treat. 2006 Jun;97(3):263-74. doi: 10.1007/s10549-005-9120-9. Epub 2005 Dec 7. Breast Cancer Res Treat. 2006. PMID: 16333527
-
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.FEBS J. 2013 Nov;280(21):5237-57. doi: 10.1111/febs.12441. Epub 2013 Aug 19. FEBS J. 2013. PMID: 23876235
-
Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.J Steroid Biochem Mol Biol. 2007 Apr;104(1-2):11-21. doi: 10.1016/j.jsbmb.2006.09.039. Epub 2007 Jan 2. J Steroid Biochem Mol Biol. 2007. PMID: 17197171
-
Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.Cancer Lett. 2009 Mar 18;275(2):204-12. doi: 10.1016/j.canlet.2008.10.022. Epub 2008 Nov 20. Cancer Lett. 2009. PMID: 19026486
-
Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.BMC Cancer. 2012 Oct 6;12:458. doi: 10.1186/1471-2407-12-458. BMC Cancer. 2012. PMID: 23039365 Free PMC article.
Cited by
-
Epithelial-mesenchymal Transition is Associated with Acquired Resistance to 5-Fluorocuracil in HT-29 Colon Cancer Cells.Toxicol Res. 2015 Jun;31(2):151-6. doi: 10.5487/TR.2015.31.2.151. Toxicol Res. 2015. PMID: 26191381 Free PMC article.
-
Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells.Int J Mol Sci. 2022 Sep 26;23(19):11340. doi: 10.3390/ijms231911340. Int J Mol Sci. 2022. PMID: 36232636 Free PMC article.
-
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.J Clin Med. 2021 May 29;10(11):2403. doi: 10.3390/jcm10112403. J Clin Med. 2021. PMID: 34072345 Free PMC article. Review.
-
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18. doi: 10.1016/j.drup.2010.07.001. Epub 2010 Aug 9. Drug Resist Updat. 2010. PMID: 20692200 Free PMC article. Review.
-
Cancer epigenetics: a perspective on the role of DNA methylation in acquired endocrine resistance.Chin J Cancer. 2011 Nov;30(11):749-56. doi: 10.5732/cjc.011.10128. Chin J Cancer. 2011. PMID: 22035855 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous